Relationship Between DNA Topoisomerase Ⅱ Alpha Expression and Prognosis in Craniopharyngiomas

XU Jianguo,YOU Chao,ZHOU Liangxue,CAI Bowen,JIANG Shu,HE Min

DOI: https://doi.org/10.3969/j.issn.1671-2897.2006.05.011

2006-01-01

Abstract:Objective To detect the expression status of DNA topoisomerase Ⅱ alpha (DNA TopoⅡα) in craniopharyngioma tissues, analyze the relationship between DNA TopoⅡα expression and tumor recurrence, and determine whether DNA TopoⅡα may be a valuable index in judging the prognosis of craniopharyngiomas. Methods The prospective cohort study program was designed. The expression level of DNA TopoⅡα was investigated by immunohistochemical avidin-biotin-peroxidase complex (ABC) method in 63 cases of tissue sections of craniopharyngioma. The quantitative analysis for DNA TopoⅡα expression was performed by using TE2000-U inverted biological microscopy and Image-Pro Plus professional image analysis software. The proliferative potential of oncocytes was evaluated in matched groups, such as adamantine epitheliomas (AE) and squamous papillary tumors (SP), recurrence and recurrence-free groups, as well as primary and relapse groups.Results Fourteen of 32 cases of AE and 6 of 31 cases of SP recurred during follow-up period. There were significant differences on DNA TopoⅡα expression level both between AE and SP groups, and between recurrence and recurrence-free groups (P0.05, two-tailed), but there was not significant difference on DNA TopoⅡα expression level between primary and relapse groups (P0.05). Conclusion The pathological subtypes of craniopharyngiomas and DNA TopoⅡα expression level are related with the prognosis of craniopharyngiomas. There was not significant difference in DNA TopoⅡα expression level between primary and relapse groups, which indicates that the proliferative activity of craniopharyngioma cells has not changed during recurring process.